Five events below are documented in sources any Canadian clinic or care home can open and read: a 12-hospital Clostridium difficile epidemic in Quebec, a carbapenemase-producing Enterobacterales outbreak in a Toronto burn centre, Canada's first Candida auris cluster, a vancomycin-resistant Enterococcus strain that crossed hospital boundaries, and a device-associated mycobacterial alert that triggered retrospective reviews across the country. Each case is set out the same way: how it was detected, how the organism moved, the infection prevention and control gap the investigators named, and what the health system changed afterwards. Four of the five turn on the same practical question a reprocessing room already answers every day — whether a shared device, a shared water source or a reused item was actually clean before it was used again.
| Quick facts | Detail |
|---|---|
| Organisms covered | Clostridioides difficile, carbapenemase-producing Enterobacterales (CPE), Candida auris, vancomycin-resistant Enterococcus faecium, Mycobacterium chimaera |
| Settings covered | Acute care hospitals, a regional burn centre, a critical care and medical ward cluster, a device used in cardiac surgery |
| Jurisdictions with published material | Quebec, Ontario, British Columbia, national surveillance through the Canadian Nosocomial Infection Surveillance Program (CNISP) |
| What every case shares | A named infection prevention and control gap, not an unexplained event |
| Where the gaps cluster | Environmental reservoirs, device water systems, patient movement, and cleaning or disinfection that was assumed to be adequate |
What makes an outbreak "documented" in Canada?
Canada has no single national outbreak register that a clinic can browse. What it has is a set of published routes. Provincial public health units must disclose infection prevention and control lapses publicly under their own disclosure protocol. Academic hospitals publish their own outbreak investigations. The Public Health Agency of Canada collects hospital-level surveillance through CNISP and publishes the findings in the Canada Communicable Disease Report and in peer-reviewed journals. A case qualifies for this article only if the source names the organism, the setting and the response, and if the source can be reached and read by a third party.
That standard matters because the same organisms circulate quietly. Canadian acute care surveillance between 2018 and 2022 reported continued healthcare-associated infection and antimicrobial resistance pressure across participating hospitals, which is why the individual investigations below are worth reading rather than the headline rates alone.
Case 1: Why did 12 Quebec hospitals share one C. difficile strain?
In March 2003, several hospitals in Quebec recorded a marked increase in Clostridium difficile-associated diarrhoea. A prospective study was run in 2004 across 12 Quebec hospitals, with a case-control component to identify risk factors.
Detection and scale: 1,703 patients with 1,719 episodes of nosocomial C. difficile-associated diarrhoea were identified, an incidence of 22.5 per 1,000 admissions. The 30-day attributable mortality rate was 6.9 percent.
Transmission chain: the outbreak was clonal. A predominant strain resistant to fluoroquinolones was present in 129 of 157 isolates, or 82.2 percent. Binary toxin genes and partial deletions in the toxin A and B repressor gene were present in 132 isolates, or 84.1 percent. Case patients were more likely than matched controls to have received fluoroquinolones or cephalosporins.
Gap named: the published conclusion was that a fluoroquinolone-resistant strain carrying binary toxin and a partial deletion of the tcdC gene was responsible for the outbreak, with antimicrobial exposure as a risk factor. The clonal pattern across a dozen institutions also showed that single-site cleaning and contact precautions were not containing an organism that survives on surfaces and spreads with shared patient-care items.
What changed: Quebec responded with provincial surveillance of C. difficile-associated diarrhoea in general and specialised hospital centres, and with provincial prevention and control guidance for nosocomial C. difficile.
Case 2: What did a carbapenemase outbreak in a Toronto burn centre reveal about sinks?
This investigation was published by the infection prevention and control team and clinicians of the Ross Tilley Burn Centre at Sunnybrook Health Sciences Centre in Toronto.
Detection and scale: over a period of two and a half months, four nosocomial cases of carbapenemase-producing Enterobacterales were identified in the regional burn centre. Three carried the Klebsiella pneumoniae carbapenemase gene and one the VIM gene. The first two cases appeared while there was no known CPE patient source on the unit, which is the point at which an environmental reservoir becomes the working hypothesis.
Transmission chain: the KPC gene was subsequently isolated from sink drains in three patient rooms. The investigators reasoned that hospital sink drains were the likely source and pointed to sink design and engineering as a control lever, because biofilm in a drain and the splashing it produces can re-seed a room faster than routine cleaning removes it.
Gap named: an environmental reservoir inside the patient room that standard environmental cleaning does not reach or does not eliminate.
What changed: the unit restricted admissions to patients with complex burns or burns of 10 percent or more of total body surface area, admitted patients to other inpatient units instead, suspended elective admissions, and began cohorting CPE-positive and CPE-negative patients with both nursing team separation and geographical separation. The paper is explicit that hospital-acquired CPE colonisation and infection still occurred despite rigorous practices that were already in place, which is why the sink itself entered the corrective plan.
Case 3: How was Canada's first Candida auris cluster contained in two months?
Detection and scale: the first reported Canadian outbreak of Candida auris was a healthcare-associated cluster in the Greater Vancouver area in 2018. Four cases were identified through passive and ring surveillance of the affected wards. Over a four-month period, more than 700 swabs were collected in order to screen 180 contacts.
Transmission chain: whole genome sequencing found that all isolates clustered together and belonged to the South Asian clade. None carried FKS gene mutations associated with resistance to echinocandins. Candida auris is difficult to identify accurately with routine methods, is reported as multidrug resistant, has published mortality rates of 30 to 60 percent, and persists in the environment in a way that supports human-to-human transmission.
Gap named: environmental persistence plus the screening delay that comes with a yeast that routine identification can misread. Contact tracing had to be built by hand, ward by ward.
What changed: the response combined surveillance, staff education, cleaning and disinfection, patient cohorting, isolation and hand hygiene. The outbreak was declared over within two months, and the authors concluded that strict infection control combined with microbiological screening can halt transmission, while noting that the case for active prospective screening remains unclear.
Case 4: What did VRE sequence type 1478 show about moving patients between hospitals?
Detection and scale: this was a retrospective review of patients with bloodstream infection caused by a novel sequence type, ST1478, of vancomycin-resistant Enterococcus faecium, across hospitals participating in the Canadian Nosocomial Infection Surveillance Program. From 2013 to 2018, VRE bloodstream isolates from participating hospitals were typed at the National Microbiology Laboratory.
Transmission chain: ST1478 bloodstream infections occurred predominantly in a small number of hospitals in central and western Canada. Inside those hospitals, infections clustered on certain wards, and isolates often differed by fewer than 20 single-nucleotide variants from one another, indicating a large component of within-hospital spread. Genomic analysis also found closely related isolates, again within 20 single-nucleotide variants, at multiple different hospitals, and some patients were recorded moving from one hospital to another, a pattern the authors identified as a potential route of inter-hospital spread.
Gap named: the combination of ward-level cross-transmission and transfer of already-colonised patients between facilities, where neither site sees the full picture.
What changed: a national surveillance and typing pathway that lets a single hospital recognise that its isolates belong to a strain already circulating elsewhere, which is the precondition for coordinated rather than local action.
Case 5: What did the heater-cooler device alert require Canadian hospitals to do?
Detection and scale: Canadian hospitals were alerted to the risk of Mycobacterium chimaera infection associated with heater-cooler units through alerts issued by the United States Food and Drug Administration and the Centers for Disease Control and Prevention. The organism is a non-tuberculous mycobacterium rather than one of the classic multidrug-resistant bacteria, and it is included here because the route of exposure is the same one the other four cases turned on: a shared water reservoir inside a device.
Transmission chain: heater-cooler units are water-based systems used to regulate patient temperature during cardiopulmonary bypass. Contamination of the unit's water circuit can produce an aerosol in the operating room, putting patients with implanted material at risk years after the procedure. That is a very different exposure geometry from direct instrument contact.
Gap named: a device's internal water system, which sits outside the instrument reprocessing cycle that sterile processing departments control.
What changed: in response to the alert, most hospitals participating in the national surveillance programme carried out retrospective reviews for infections, informed patients who had been exposed, and made informed consent a requirement before a heater-cooler unit was used.
Where do shared equipment and reprocessing actually sit in these five cases?
| Case | Shared item or site | Why routine practice did not cover it |
|---|---|---|
| Quebec, 2003 to 2005 | Room surfaces and shared patient-care items | A surface-surviving organism moved between institutions faster than terminal cleaning and contact precautions could interrupt it |
| Toronto burn centre, 2022 | Sink drains in three patient rooms | An environmental reservoir inside the room that cleaning does not reach, and splashing that re-seeds surfaces |
| Greater Vancouver, 2018 | Room environment and shared ward equipment | A yeast that persists on surfaces and resists identification, so cleaning had to be paired with screening and cohorting |
| CNISP hospitals, 2013 to 2018 | Ward equipment and transferred patients | Cross-transmission on a ward plus movement of patients between facilities, with no single site seeing the whole chain |
| Canadian hospitals, 2016 onward | The water circuit inside a heater-cooler unit | A device water system sits outside the instrument reprocessing cycle, so the standard decontamination workflow never touches it |
Four of the five cases are, in practical terms, reprocessing problems wearing different clothes. A sink drain is a surface that was never on a cleaning schedule. A device water circuit is a lumen that was never disassembled. A ward item that moves between patients is a semi-critical or non-critical surface that relies entirely on the cleaner-disinfectant decision made at the point of use. And the Quebec epidemic showed how quickly an organism that survives on surfaces becomes an institutional problem once several sites are involved.
Which gaps repeat across the five cases?
| Gap type | Cases where it appears | What a facility can actually check |
|---|---|---|
| Environmental reservoir not covered by the cleaning schedule | Quebec; Toronto burn centre; Greater Vancouver | Drains, splash zones, and the distance a cleaner actually reaches around a sink or a clinical basin |
| Device water or plumbing that reprocessing never touches | Toronto burn centre; heater-cooler units | The manufacturer's water-management and disinfection instructions for every device with a reservoir |
| Movement of colonised patients or items between sites | CNISP VRE; Quebec | Transfer documentation that carries colonisation status, and item-level traceability for reusable equipment |
| Assumption that routine decontamination is sufficient | All five | Records that show the step happened, at the concentration and contact time the label or standard requires |
| Screening and detection delay | Greater Vancouver; CNISP VRE | Whether the laboratory pathway can identify the organism and whether surveillance is passive or active |
The pattern is consistent with how guidance now frames the problem. National guidance for carbapenemase-producing Enterobacterales in Canadian healthcare settings includes a dedicated outbreak-management section, which is where the assumption that a facility's normal routine is enough gets tested. That is also where the reprocessing chain, the cleaning product, the record and the transfer form stop being paperwork and start being the actual control.
The practical consequence is that a facility ends up maintaining two records at once: what it did to the room and the device, and what the sterilization cycle itself actually achieved. The second half is what a self-contained biological indicator is for, and the arithmetic is small — one indicator per sterilizer per day it is used, per cycle type. A 24-hour self-contained biological indicator in a 50-pack covers a single-autoclave clinic for roughly two months of daily testing, and a 5-pack trial of the same indicator is the lowest-cost way to run the first week before committing to a case quantity. Care homes and multi-site groups ordering across departments usually route those orders through the institutional account channel, which keeps cycle-level records under one account rather than across several. Reselling? become a distributor.
Where to go next: the printable monitoring log and the digital compliance log at our sterilization compliance log centre let a reprocessing room record the steps it already performs, which is the evidence an environmental reservoir investigation will ask for.
Have a question about your own facility? Send it in and you will get a written answer specific to your setup, with the regulation or standard it is based on cited. Ask your compliance question.
Related reading
- Ontario infection control enforcement: 5 public cases and what each one teaches
- Laboratory-acquired infections: 3 documented outbreaks and the supply-chain failures behind them
- Case review: outbreak-season reprocessing frequency in an Ontario retirement home
- The true cost of a sterilization lapse: lessons from an Ontario clinic's 884-patient case
The wider reference set for Canadian facilities sits in the sterilization compliance hub.
Frequently Asked Questions
Are multidrug-resistant organism outbreaks common in Canada?
Published Canadian data is thinner than in the United States, which is why the cases in this article are individual investigations rather than a national count. National hospital surveillance continues to report healthcare-associated infection and antimicrobial resistance pressure in participating acute care hospitals, and provincial public health units publish infection prevention and control lapses on their own websites, so the events are visible even without a single national register.
Which organism caused the largest documented Canadian outbreak described here?
By patient count, the Quebec Clostridium difficile epidemic, studied prospectively across 12 hospitals, identified 1,703 patients with 1,719 episodes of nosocomial infection, an incidence of 22.5 per 1,000 admissions and a 30-day attributable mortality rate of 6.9 percent.
Was any of these outbreaks traced to a contaminated instrument?
None of the five was traced to a failure of the instrument sterilization cycle itself. What the investigations named were an environmental reservoir in sink drains, environmental persistence of a yeast, ward-level cross-transmission combined with patient transfer, and the water circuit inside a device. Those are adjacent to instrument reprocessing and are usually managed by the same team.
Why is Candida auris treated as a special case?
Because it is hard to identify accurately with routine laboratory methods, is reported as multidrug resistant, has published mortality rates of 30 to 60 percent, and persists in the environment in a way that supports transmission between people. In the Greater Vancouver cluster, all isolates clustered together by whole genome sequencing and belonged to the South Asian clade.
What is the single most useful record a clinic can keep against this risk class?
A record that shows the decontamination step happened, at the concentration and contact time the product label or the applicable standard requires, on the specific item or surface. Investigations of this kind ask whether a step was verified rather than whether it was scheduled, and a log that captures the product, the dilution, the contact time and the item is what answers that question.
Does Ontario require weekly biological indicator testing?
No. Ontario's requirement is a biological indicator in a process challenge device for each sterilizer on each day it is used and for each type of cycle used on that day. A weekly cadence appears in United States guidance and in ANSI/AAMI ST79, and it is used here only as a comparison baseline; it is not the Ontario requirement.
Where can a care home or clinic see the underlying documents?
Every case above is linked in the sources list below, and the underlying investigations are published by the hospital or surveillance programme that ran them, the Public Health Agency of Canada, or the journal that carried the investigation report.
Sources
- A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality — New England Journal of Medicine, 2005
- Outbreak of carbapenemase-producing Enterobacteriaceae in a regional burn centre — Journal of Burn Care and Research, 2022
- First reported outbreak of the emerging pathogen Candida auris in Canada — American Journal of Infection Control, 2021
- Vancomycin-resistant Enterococcus sequence type 1478 spread across hospitals participating in the Canadian Nosocomial Infection Surveillance Program from 2013 to 2018 — Infection Control and Hospital Epidemiology, 2023
- Response to alert on possible infections with Mycobacterium chimaera from contaminated heater-cooler devices in hospitals participating in CNISP — Infection Control and Hospital Epidemiology, 2018
- Carbapenemase-producing Enterobacterales prevention and control in Canadian healthcare settings — Public Health Agency of Canada, June 2026
- Infection prevention and control lapse involving medical equipment reprocessing at a family medicine clinic in Ottawa, Ontario, 2018 — Canada Communicable Disease Report, 2020
- Carbapenemase-producing Enterobacteriaceae in Ontario: 2022 — Public Health Ontario
- Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals — Canada Communicable Disease Report, 2026
- Guidance for preventing and controlling Clostridium difficile-associated diarrhoea in Quebec healthcare settings — Institut national de santé publique du Québec
CliniEco Medical supplies sterilization monitoring consumables and clinical consumables to Canadian dental clinics, long-term care homes, veterinary practices and laboratories. CliniEco Medical holds MDEL #35334.
0 comments